Table 3.
Results of OLS estimation: Association of adherence and VAS-AL
| N = 116 patients | VAS-AL | VAS-AL (adherent in presence of side effects) | ||||
|---|---|---|---|---|---|---|
| 3-year adherence | Estimate | SE | Pr > |t| | Estimate | SE | Pr > |t| |
| Adherence to medication | 0.21 | 0.14 | 0.1263 | 0.40 | 0.18 | 0.0270 |
| Adherence to recommendations | −0.06 | 0.10 | 0.5159 | −0.08 | 0.10 | 0.4033 |
All results are controlled for baseline variables (BMI, NYHA, Age, gender, number of comorbidities) and stressful event in follow-up
BMI body mass index, NYHA classification of heart failure of the New York Heart Association, SE standard error, VAS visual analog scale, VAS-AL VAS-adjusted life years, LME linear mixed effects